- 行业分类
- 药品资讯网－－－新药研发行业门户，新药研发企业首选信息网站！
- 发布信息
- 综合性医院儿科护理工作满意度调查与分析
- 颅脑损伤病人发热的护理
- 发挥护士在ADR监测中的作用保障病人用药安全
- 妇科择期手术病人术前禁食现状与对策
- 慢传输型便秘发病机制研究进展
- erbB4／HER4基因和乳腺癌
- 以发热、败血症为首发表现的十二指肠乳头癌一例
- 胰岛素抵抗与动脉粥样硬化
- 慢性心力衰竭治疗进展
- 硝酸酯在心血管病中应用的新认识
- 耐药不动杆菌AmpC酶及其相关基因分析
- 宁波地区大肠埃希菌和肺炎克雷伯菌质粒AmpC酶基因检测
- 布地奈德雾化治疗中重度慢性阻塞性肺疾病急性加重期的随机临床试验
- 门诊病人行经桡动脉途径冠状动脉造影术的可行性
- 组织多普勒成像技术结合小剂量多巴酚丁胺负荷试验评估存活心肌
- 老年心血管病患者不遵医行为的调查与对策
- 脑利钠肽评估急性心肌梗死预后的病例对照观察
- 三分三浸膏片对高尿酸血症小鼠血清尿酸含量的影响
- 自体输血等综合节血措施在体外循环心脏手术中的应用
- 不同灌注液对人离体小动脉保护作用的超微观察
- 经胸膜外微创手术治疗小儿动脉导管未闭
- 小儿法洛四联症外科治疗19例分析
- 总胆固醇、甘油三酯和低密度脂蛋白胆固醇试剂对脂肪酶测定结果的影响
- 慢性阻塞性肺疾病呼吸衰竭的APACHEⅡ评分
- 慢性阻塞性肺疾病伴Ⅱ型呼吸衰竭间歇无创正压通气合用尼可刹米的疗效
- 低温等离子射频消融治疗儿童睡眠呼吸暂停低通气综合征
- 反复呼吸道感染患儿免疫功能状态变化的临床意义
- 烧伤患者医院获得性肺炎临床分析
- 鼻咽癌一家系报告
- 426株肺炎克雷伯菌超广谱β-内酰胺酶检测及药敏分析
- 联合检测胸水C反应蛋白和腺苷脱氨酶在胸腔积液诊断中的价值
- 选择性子宫动脉插管化疗及栓塞治疗输卵管妊娠
- IUPAC Name: N-[[(4-butoxyphenyl)amino]-sulfanylmet
- AIDS154875,AIDS-154875,(3aR,7aR)-2-{1-[4-({4-[(3aS
- AIDS094597,AIDS-094597,8-[3-(1-Amino-cyclohexyl)-p
- IUPAC Name: 3-[bis(2-chloroethyl)aminomethyl]-4-me
- AIDS112273,AIDS-112273,5-Pyrimidinecarboxylic acid
- IUPAC Name: 6-[(hydroxyamino)-(5,5,8,8-tetramethyl
- AIDS137872,AIDS-137872,NSC643424,3-(4-Chlorophenyl
- IUPAC Name: 9,9-dimethyl-9-azoniabicyclo[3.3.1]non
- AIDS156176,AIDS-156176,NSC245398,NSC 245398,4-meth
- ma'iliohydrin ,NSC719212,NCI60_040966,
- IUPAC Name: 2,,2-dichloro-1-[4-[2-hydroxy-2-(4-nit
- IUPAC Name: octylsulfanylmethanedithioic acid,Cano
- IUPAC Name: 2-methanidyl-3,3-dimethylbut-1-ene; pa
- IUPAC Name: 2-[(3R,4S,6R)-6-ethyl-6-(4-ethylocta-1
- IUPAC Name: chromium; oxalic acid,Canonical SMILES
- Viburnitol,d-Quercitol,(-)-Viburnitol,D-1-deoxy-my
- IUPAC Name: 4,5-dichloro-2-[[3-chloro-4-(3,,4-dich
- AIDS093674,AIDS-093674,(4-Chloro-benzyl)-(3-morpho
- IUPAC Name: N-(4,5-dihydro-1H-imidazol-2-ylmethyl)
- Thioethyl compound,Ethyl thiopyrazinoate,AIDS09510
- NSC318738,1,4-Diazoniabicyclo[2.2.1]heptane, 1,4-b
- IUPAC Name: trimethyl-(2-naphthalen-2-ylethyl)azan
- AIDS113321,AIDS-113321,(+/-)-rel-Piperidine, 1-[[(
- IUPAC Name: piperidin-1-ide; 2H-pyridin-1-ide; tet
- AIDS107784,AIDS-107784,Butyl{5-[(2-methylbenzimida
- IUPAC Name: 1-(2,3-dimethylphenyl)-2-propan-2-ylgu
- IUPAC Name: ethyl 2-piperidin-2-ylacetate,Canonica
- IUPAC Name: 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahyd
- NSC722913,3-(4-methylphenyl)-4-(4-nitrophenyl)isot
- AIDS108538,AIDS-108538,4-{[3-Amino-5-(2,4,6-triflu
- IUPAC Name: 2-methylidene-3-oxocyclopentane-1-carb
- Osanetant, SR-142806((S)-isomer), SR-142801(monoHC
- Motexafin gadolinium, Gadolinium texaphyrin, PCI-0
- L-733060,148700-84-9, 148700-91-8 ((-)-cis-isomer)
- Alvameline tartrate, LU-25-109(free base), LU-25-1
- Rizatriptan benzoate, MK-462, MK-0462, Maxalt-MLT,
- EMD-57439((-)-enantiomer), EMD-53998(racemate), EM
- Labradimil, Lobradimil, Receptor mediated permeabi
- OPB-3206,,3(R)-Isobutyl-4-[1-methoxy-2-oxo-1,2,3,4
- Compound 73/602, CDRI-73/602,60811-32-7,7-Methoxy-
- DP-543, DMP-543, XR-543,160588-45-4,10,10-Bis(2-fl
- NCA-0424,161224-75-5,2-Methyl-2-(6-methylindolo[2,
- Proxodolol,152289-59-3, 158446-41-4 (error in CA),
- Rimonabant hydrochloride, SR-141716A, Acomplia,158
- Lanicemine hydrochloride, AR-R15896AR, FPL-15895AR
- IsoddA-(S,S), 191W91,143191-77-9,(2S,4S)-9-[2-(Hyd
- ,,4-[2-[1-(4,4'-Dipropylbenzhydryl)indole-5-carbox
- ,,(+)-6-Fluoro-1(R)-(fluoromethyl)-7-(4-methylpipe
- ,,(-)-6-Fluoro-1(S)-(fluoromethyl)-7-(4-methylpipe
- Gadoxetic acid disodium salt, Gadoxate disodium, G
- Aspalatone, AAME, BK-111,147249-33-0,Acetylsalicyl
- Avasimibe, CI-1011,166518-60-1, 166518-61-2 (sodiu
- OPC-29030,161190-38-1,(S)-(+)-6-[3-[1-(2-Methylphe
- RWJ-50172,155201-46-0,N-(2,6-Difluorophenyl)-3-oxo
- Nalfurafine hydrochloride, TRK-820,152658-17-8, 15
- Olmesartan medoxomil, CS-866DM, CS-866, Olmetec, B
- JTV-519, K-201,145903-06-6,4-[3-(4-Benzylpiperidin
- Clevudine, Levovir, L-FMAU,163252-36-6,1-(2'-Deoxy
- CT-2584, Apra,160944-05-8 (racemate),1-[11-(Dodecy
- FR-161282,168046-41-1, 168046-43-3 (monomesylate s
- OSA-8302,162478-72-0,13,14-Dihydroprostaglandin F2
- Omapatrilat, BMS-186716, Vanlev,167305-00-2,(4S,7S
- V-11294A,162278-09-3,3-[3-(Cyclopentyloxy)-4-metho
- 行业资讯
- 进入专业资料首页
卫生部：0-6个月婴幼儿配方食品不得添加
据卫生部网站消息，卫生部今日发布并施行《婴幼儿配方食品和谷类食品中香料使用规定》。 &....[详细]
- 人才招聘
- 进入人才首页
